1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [2013831d-ac3d-4748-95a7-5bb164ae4858] => Array
        (
            [runtime-id] => 2013831d-ac3d-4748-95a7-5bb164ae4858
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [b0f9b8d2-2dca-40e5-902a-363a8427b34e] => Array
                        (
                            [runtime-id] => b0f9b8d2-2dca-40e5-902a-363a8427b34e
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b8fa1bb3ef9fa8dede9d201ce66a98164c5787dc
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [7e73febf-dfda-41c1-b6e2-2972c93c7b66] => Array
        (
            [runtime-id] => 7e73febf-dfda-41c1-b6e2-2972c93c7b66
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [c6370b5b-c47e-4c63-958c-b56a9d9f6b40] => Array
                        (
                            [runtime-id] => c6370b5b-c47e-4c63-958c-b56a9d9f6b40
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b8fa1bb3ef9fa8dede9d201ce66a98164c5787dc
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [7e73febf-dfda-41c1-b6e2-2972c93c7b66] => Array
        (
            [runtime-id] => 7e73febf-dfda-41c1-b6e2-2972c93c7b66
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [c6370b5b-c47e-4c63-958c-b56a9d9f6b40] => Array
                        (
                            [runtime-id] => c6370b5b-c47e-4c63-958c-b56a9d9f6b40
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b8fa1bb3ef9fa8dede9d201ce66a98164c5787dc
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [7e73febf-dfda-41c1-b6e2-2972c93c7b66] => Array
        (
            [runtime-id] => 7e73febf-dfda-41c1-b6e2-2972c93c7b66
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [c6370b5b-c47e-4c63-958c-b56a9d9f6b40] => Array
                        (
                            [runtime-id] => c6370b5b-c47e-4c63-958c-b56a9d9f6b40
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b8fa1bb3ef9fa8dede9d201ce66a98164c5787dc
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [7e73febf-dfda-41c1-b6e2-2972c93c7b66] => Array
        (
            [runtime-id] => 7e73febf-dfda-41c1-b6e2-2972c93c7b66
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [c6370b5b-c47e-4c63-958c-b56a9d9f6b40] => Array
                        (
                            [runtime-id] => c6370b5b-c47e-4c63-958c-b56a9d9f6b40
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b8fa1bb3ef9fa8dede9d201ce66a98164c5787dc
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [7e73febf-dfda-41c1-b6e2-2972c93c7b66] => Array
        (
            [runtime-id] => 7e73febf-dfda-41c1-b6e2-2972c93c7b66
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [c6370b5b-c47e-4c63-958c-b56a9d9f6b40] => Array
                        (
                            [runtime-id] => c6370b5b-c47e-4c63-958c-b56a9d9f6b40
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b8fa1bb3ef9fa8dede9d201ce66a98164c5787dc
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [39f1579e-d0f3-4c40-8153-6872daead9e0] => Array
        (
            [runtime-id] => 39f1579e-d0f3-4c40-8153-6872daead9e0
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [0c409a1f-4c3e-4aaa-b9bf-4f1c6d73e06c] => Array
                        (
                            [runtime-id] => 0c409a1f-4c3e-4aaa-b9bf-4f1c6d73e06c
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b8fa1bb3ef9fa8dede9d201ce66a98164c5787dc
                )

        )

)


  
    











    Head, Neck, and Brain Tumor Embolization | American Journal of Neuroradiology  
    


















    


























    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

  

    

  
      
  
  

    

  
  
      
Research ArticleArticles

  
      

  
      
Head, Neck, and Brain Tumor Embolization
  
  
    	
American Journal of Neuroradiology September 2001,  22 (8 suppl) S14-S15; 

  
  
  



  


  
  



  
      
  
  

    
Introduction
The embolization of vascular tumors of the head, neck, and CNS has become an important adjunct to the surgical treatment of these tumors. The procedure has resulted in reduced morbidity and mortality and helps to facilitate the removal of many of these tumors. In tumors that are not amenable to surgical therapy, embolization may occasionally be used as the primary mode of treatment.
These guidelines are to be used in quality improvement programs to assess head, neck, and brain tumor embolization procedures. The most important processes of care are patient selection, performing the procedure, and monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates. Outcome measures are assigned threshold levels.
Definitions
Tumor embolization is defined as the blockage of the vascular supply to a tumor. The blockage is usually performed via an endovascular approach but may also be performed by direct percutaneous injection of embolic agents into the tumor. The procedure is usually performed in a single session, simultaneously with diagnostic arteriography, but may also be performed in multiple staged sessions.
Ideally, an embolic agent is chosen that will block the very small vessels within the tumor but spare the adjacent normal tissue. Liquid embolic agents, such as ethanol or acrylic, and powdered particulate materials can penetrate into the smallest blood vessels of the tumor but need to be used very selectively because they can also cause the most damage to the adjacent normal tissues. Relatively large particulate agents, such as polyvinyl alcohol and Gelfoam, do not penetrate into the tumor as deeply but are also less likely to damage adjacent normal tissues. Embolic agents may be permanent or temporary.
For the purposes of these guidelines, a threshold is a specific level of an indicator that should prompt a review. “Procedure thresholds” or “overall thresholds” reference a group of indicators for a procedure (eg, major complications). Individual complications may also be associated with complication-specific thresholds.
When measures such as indications or success rates fall below a (minimum) threshold, or when complication rates exceed a (maximum) threshold, a review should be conducted to determine causes and to implement changes, if necessary. For example, if the incidence of a complication such as unexpected cranial nerve palsy is one measure of the quality of tumor embolization, values in excess of the defined threshold for this complication (in this case, 4%) should prompt a review of the policies and procedures within the department to determine the causes and to implement changes to lower the incidence of the complication.
Complications can be stratified on the basis of outcome. Major complications result in prolonged admission to a hospital for therapy, an unplanned increase in the level of care, permanent adverse sequelae, or death. Minor complications result in minimal or no sequelae; they may require nominal therapy or a short hospital stay for observation (generally overnight). The complication rates and thresholds below refer to major complications.
Indications
There is a great variability in the location of tumors in the head, neck, and CNS, with some tumors being easier to remove and others being more difficult. There is also variability in the expertise of the surgeon in dealing with various tumors. Thus, the indications for tumor embolization must be stated in general terms. The prerequisite to preoperative tumor embolization is a vascular mass. The indications for embolization include the following: 1) to control surgically inaccessible arterial feeders, 2) to decrease surgical morbidity by reducing blood loss, 3) to shorten the operative procedure time, 4) to increase the chances of complete surgical resection, 5) to decrease the risk of damage to adjacent normal tissue, 6) to relieve intractable pain, 7) to decrease expected tumor recurrence, and 8) to allow better visualization of the surgical field with decreased overall surgical complication.
Hypervascular tumors for which embolization may be indicated include hemangioblastomas, intracranial metastases, meningiomas, hemangiopericytomas, neurogenic tumors (eg, schwannomas), paragangliomas, juvenile nasopharyngeal angiofibromas, hemangiomas, esthesioneuroblastomas, benign bone tumors, malignant bone tumors, and extracranial metastases. A vascular tumor in the head and neck region or in the CNS in a surgically treatable patient for whom it is deemed that embolization would be a benefit, as described above, is a candidate for embolization. Palliative embolization of head, neck, and CNS tumors may be indicated as the sole treatment for patients who are at poor risk for surgery, radiation therapy, and chemotherapy for intractable pain, intractable hemorrhage, or increasing neurologic deficits.
Threshold: 100%
When <100% of the procedures are performed for the above indications, a review should be conducted.
Efficacy
A review of the literature supports the benefits of embolization to facilitate the surgical resection of vascular tumors by reducing intraoperative blood loss. The indictors of efficacy are technical and clinical success. Technical success is defined as occlusion of the targeted vessels. Clinical success is a decrease in the expected blood loss during surgery, facilitating tumor removal and reducing surgical complication, or palliation of the symptoms described above.Formula
Safety
The most common transient complications associated with tumor embolization are fever and localized pain. Puncture site complications (eg, hematomas) are also fairly frequent and usually are of no clinical consequence unless they are very large or located where neural compromise may occur. The risk of a serious complication after tumor embolization is low. Serious complications would include nerve damage, tissue damage, stroke, or death.
Threshold:
When the following complications and corresponding thresholds are exceeded, a review should be conducted.Formula
Bibliography
  1. Macpherson P,  The value of pre-operative embolisation of meningioma estimated subjectively and objectively. Neuroradiology 1991;33:334-337
  2. Casasco A, Herbreteau D, Houdart E,  Devascularization of craniofacial tumors by percutaneous tumor puncture. AJNR Am J Neuroradiol 1994;15:1233-1239
  3. George B, Casasco A, Deffrennes D, Houdart E,  Intratumoral embolization of intracranial and extracranial tumors: technical note. Neurosurgery 1994;35:771-774
  4. Standard SC, Ahuja A, Livingston K, Guterman LR, Hopkins LN,  Endovascular embolization and surgical excision for the treatment of cerebellar and brain stem hemangioblastomas. Surg Neurol 1994;41:405-410
  5. Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT,  Angiofibroma: changes in staging and treatment. Arch Otolaryngol Head Neck Surg 1996;122:122-129
  6. Deschler DG, Kaplan MJ, Boles R,  Treatment of large juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 1992;106:278-284
  7. Bishop GB Jr, Urist MM, el Gammal T, Peters GE, Maddox WA,  Paragangliomas of the neck. Arch Surg 1992;127:1441-1445
  8. Wiet RJ, Harvey SA, O'Connor CA,  Recent advances in surgery of the temporal bone and skull base. Southern Med J 1993;86:5-12
  9. Wax MK, Briant TD,  Carotid body tumors: a review. J Otolaryngol 1992;21:277-285
  10. Abramowitz J, Dion JE, Jensen ME,  Angiographic diagnosis and management of head and neck schwannomas. AJNR Am J Neuroradiol 1991;12:977-984
  11. Manelfe C, Lasjaunias P, Ruscalleda J,  Preoperative embolization of intracranial meningiomas. AJNR Am J Neuroradiol 1986;7:963-972
  12. Richter HP, Schachenmayr W,  Preoperative embolization of intracranial meningiomas. Neurosurgery 1983;13:261-268
  13. Hieshima GB, Everhart FR, Mehringer CM,  Preoperative embolization of hemangiomas. Surg Neurol 1980;14:119-127
  14. Ahuja A, Gibbons KJ,  Endovascular therapy of central nervous system tumors. Neurosurg Clin N Am 1994;5:541-554
  15. Platzbecker H, Kohler K,  Embolization in the head and neck region. Acta Radiol Suppl 1991;377:25-26
  


  
  



  



    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement